Login / Signup

Evaluation of role of Tigecycline among clinically significant multidrug resistant pathogens from a tertiary care hospital.

Annapoorna RemashPooja RaoSuchitra ShenoyShrikala BaligaShafir Kassim
Published in: F1000Research (2024)
to tigecycline for elimination of infections caused by both Gram positive and Gram negative pathogens. The use of combination therapy becomes crucial to prevent the development of Pan Drug resistance.
Keyphrases
  • gram negative
  • multidrug resistant
  • combination therapy
  • acinetobacter baumannii
  • klebsiella pneumoniae
  • drug resistant
  • cystic fibrosis